Published studies suggest that activation of Ras-related C3 botulinum toxin substrate 1 (RAC1) induces renal damage and plays an important role in the pathogenesis and progression of DN (Lin et al., 2015; Maier et al., 2018). Here, RAC1 is linked to liver dysplastic nodule.